Results 81 to 90 of about 22,442 (179)

One Health Insights From Pteropus medius: Nipah Virus Spillover, Microbiota, and Antimicrobial Resistance

MicrobiologyOpen, Volume 15, Issue 4, August 2026.
Environmental and anthropogenic drivers of antibiotic resistance dissemination. The cycle reinforces how anthropogenic inputs, such as sewage, animal dung, hospital effluent, and agricultural runoff bring resistant bacteria and antibiotic residues into soil and water.
Punam Chowdhury, Shah Md Tanvir Khan, Sajal Roy, Md. Shohel Al Faruk   +3 more
wiley   +1 more source

Oral Health Care Services, Barriers and Enablers to Maintaining Good Oral Health in Motor Neurone Disease: A Scoping Review

Community Dentistry and Oral Epidemiology, Volume 54, Issue 4, Page 447-461, August 2026.
ABSTRACT Objectives The objective of this scoping review was to map existing literature on oral health and related care in individuals with Motor Neurone Disease (MND). Specifically, the review aimed to identify barriers and facilitators to maintaining oral hygiene, summarise available clinical guidelines and patient‐facing resources, and examine how ...
Mariam A. Khokhar, Lucy A. O'Malley, Anne‐Marie Glenny, Xiaohui Chen   +3 more
wiley   +1 more source

A Phase 2 Trial of Frexalimab, a CD40L Antagonist, in Adolescents and Adults With Recent‐Onset Type 1 Diabetes (FABULINUS): Rationale and Study Design

Diabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 6584-6594, August 2026.
ABSTRACT Introduction Type 1 diabetes (T1D) is a chronic autoimmune disease, characterised by progressive destruction of the insulin‐producing pancreatic β‐cells. Preserving remaining β‐cells at the time of diagnosis may improve long‐term outcomes. Frexalimab is a humanised monoclonal antibody specific for CD40L undergoing evaluation for treatment of ...
Andriy Cherkas, Baerbel Rotthaeuser, Niels Porksen, Pascale Labard, My‐Liên Nguyên‐Pascal, Mathieu Coudert, Baptiste Berthou, Marie Baccara‐Dinet, Gabor Boka, Mark Peakman, Felix Reschke, Michael J. Haller   +11 more
wiley   +1 more source

MicRobiological diagnosis of invasive candidiasis

Zdravniški Vestnik, 2009
background Candida spp. are responsible for opportunistic fungal infections in patients with known risk factors. Clinical diagnosis of invasive candidiasis is difficult because clinical features and symptoms are usually non-specific.
Eva Sodja, Tadeja Matos, Saša Simčič
doaj  

Candida oesophagitis as an Initial Manifestation of VEXAS Syndrome: Expanding Evidence for an Acquired Immunodeficiency Phenotype

eJHaem, Volume 7, Issue 4, August 2026.
Demi Rianne Vintges, Marina Weerheim, Faiz Karim   +2 more
wiley   +1 more source

PHARMACOECONOMIC ANALYSIS OF MICAFUNGIN USING IN THE TREATMENT OF INVASIVE CANDIDIASIS IN NEWBORNS

Педиатрическая фармакология, 2011
Invasive candidiasis is a common cause of neonatal sepsis, especially in children with very low birth weight. This study, for the first time in the world of medical research, shows the results of the clinico-economical expertise of using micafungin to ...
A.S. Kolbin, M.A. Proskurin, Yu.A. Balykina, N.N. Klimko   +3 more
doaj   +2 more sources

Candidíase invasiva e alterações bucais em recém-nascidos prematuros

Einstein (São Paulo)
OBJETIVO: Investigar a prevalência de candidíase invasiva em Unidade de Terapia Intensiva Neonatal e avaliar alterações bucais e colonização bucal por Candida spp. em recém-nascidos prematuros com baixo peso.
José Endrigo Tinoco-Araujo, Diana Ferreira Gadelha Araújo, Patrícia Gomes Barbosa, Paulo Sérgio da Silva Santos, Ana Myriam Costa de Medeiros   +4 more
doaj   +1 more source

Epidemiology and risk factors for invasive candidiasis

Therapeutics and Clinical Risk Management, 2014
Nur Yapar Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkey Abstract: The number of immunosuppressive patients has increased significantly in recent years.
Yapar N
doaj  

Anidulafungin in the treatment of invasive fungal infections

Therapeutics and Clinical Risk Management, 2008
Kathryn Sabol, Tawanda GumboUniversity of Texas Southwestern Medical Center, Dallas, TX, USAAbstract: More antifungal agents have reached clinical use in the past two decades than at any other time.
Kathryn Sabol, Tawanda Gumbo
doaj  

Mycograb for the Treatment of Invasive Candidiasis [PDF]

Clinical Infectious Diseases, 2006
Raoul, Herbrecht, Cécile, Fohrer, Yasmine, Nivoix   +2 more
openaire   +2 more sources